Cargando…
β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
Osteoporosis is a systemic metabolic bone disorder that is caused by an imbalance in the functions of osteoclasts and osteoblasts and is characterized by excessive bone resorption by osteoclasts. Targeting osteoclast differentiation and bone resorption is considered a good fundamental solution for o...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125251/ https://www.ncbi.nlm.nih.gov/pubmed/34062884 http://dx.doi.org/10.3390/molecules26092665 |
_version_ | 1783693446059393024 |
---|---|
author | Park, Gyeong Do Cheon, Yoon-Hee Eun, So Young Lee, Chang Hoon Lee, Myeung Su Kim, Ju-Young Cho, Hae Joong |
author_facet | Park, Gyeong Do Cheon, Yoon-Hee Eun, So Young Lee, Chang Hoon Lee, Myeung Su Kim, Ju-Young Cho, Hae Joong |
author_sort | Park, Gyeong Do |
collection | PubMed |
description | Osteoporosis is a systemic metabolic bone disorder that is caused by an imbalance in the functions of osteoclasts and osteoblasts and is characterized by excessive bone resorption by osteoclasts. Targeting osteoclast differentiation and bone resorption is considered a good fundamental solution for overcoming bone diseases. β-boswellic acid (βBA) is a natural compound found in Boswellia serrata, which is an active ingredient with anti-inflammatory, anti-rheumatic, and anti-cancer effects. Here, we explored the anti-resorptive effect of βBA on osteoclastogenesis. βBA significantly inhibited the formation of tartrate-resistant acid phosphatase-positive osteoclasts induced by receptor activator of nuclear factor-B ligand (RANKL) and suppressed bone resorption without any cytotoxicity. Interestingly, βBA significantly inhibited the phosphorylation of IκB, Btk, and PLCγ2 and the degradation of IκB. Additionally, βBA strongly inhibited the mRNA and protein expression of c-Fos and NFATc1 induced by RANKL and subsequently attenuated the expression of osteoclast marker genes, such as OC-STAMP, DC-STAMP, β3-integrin, MMP9, ATP6v0d2, and CtsK. These results suggest that βBA is a potential therapeutic candidate for the treatment of excessive osteoclast-induced bone diseases such as osteoporosis. |
format | Online Article Text |
id | pubmed-8125251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81252512021-05-17 β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways Park, Gyeong Do Cheon, Yoon-Hee Eun, So Young Lee, Chang Hoon Lee, Myeung Su Kim, Ju-Young Cho, Hae Joong Molecules Article Osteoporosis is a systemic metabolic bone disorder that is caused by an imbalance in the functions of osteoclasts and osteoblasts and is characterized by excessive bone resorption by osteoclasts. Targeting osteoclast differentiation and bone resorption is considered a good fundamental solution for overcoming bone diseases. β-boswellic acid (βBA) is a natural compound found in Boswellia serrata, which is an active ingredient with anti-inflammatory, anti-rheumatic, and anti-cancer effects. Here, we explored the anti-resorptive effect of βBA on osteoclastogenesis. βBA significantly inhibited the formation of tartrate-resistant acid phosphatase-positive osteoclasts induced by receptor activator of nuclear factor-B ligand (RANKL) and suppressed bone resorption without any cytotoxicity. Interestingly, βBA significantly inhibited the phosphorylation of IκB, Btk, and PLCγ2 and the degradation of IκB. Additionally, βBA strongly inhibited the mRNA and protein expression of c-Fos and NFATc1 induced by RANKL and subsequently attenuated the expression of osteoclast marker genes, such as OC-STAMP, DC-STAMP, β3-integrin, MMP9, ATP6v0d2, and CtsK. These results suggest that βBA is a potential therapeutic candidate for the treatment of excessive osteoclast-induced bone diseases such as osteoporosis. MDPI 2021-05-01 /pmc/articles/PMC8125251/ /pubmed/34062884 http://dx.doi.org/10.3390/molecules26092665 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Gyeong Do Cheon, Yoon-Hee Eun, So Young Lee, Chang Hoon Lee, Myeung Su Kim, Ju-Young Cho, Hae Joong β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways |
title | β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways |
title_full | β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways |
title_fullStr | β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways |
title_full_unstemmed | β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways |
title_short | β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways |
title_sort | β-boswellic acid inhibits rankl-induced osteoclast differentiation and function by attenuating nf-κb and btk-plcγ2 signaling pathways |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125251/ https://www.ncbi.nlm.nih.gov/pubmed/34062884 http://dx.doi.org/10.3390/molecules26092665 |
work_keys_str_mv | AT parkgyeongdo bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways AT cheonyoonhee bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways AT eunsoyoung bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways AT leechanghoon bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways AT leemyeungsu bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways AT kimjuyoung bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways AT chohaejoong bboswellicacidinhibitsranklinducedosteoclastdifferentiationandfunctionbyattenuatingnfkbandbtkplcg2signalingpathways |